The price of Aimovig can vary. In the United States, Aimovig typically costs around $6,800 annually, which breaks down to approximately $567 per month [1]. However, this price does not reflect any discounts or patient assistance programs [1].
What factors influence Aimovig's cost?
The list price of Aimovig is influenced by several factors, including manufacturing expenses, research and development investment, and the drug's therapeutic value in treating migraine [1]. These costs are then passed on to consumers and healthcare systems.
How can Aimovig's price be reduced?
Several avenues exist for reducing the out-of-pocket cost of Aimovig.
* Manufacturer Discounts and Patient Assistance Programs: Amgen, the maker of Aimovig, offers programs that can significantly lower the cost for eligible patients [2]. For instance, commercially insured patients may pay as little as $5 per month through savings programs [2].
* Insurance Coverage: The extent of coverage by private or government insurance plans plays a crucial role in the final price a patient pays.
* Pharmacy and Location: Prices can also differ slightly between pharmacies and across different geographical regions [1].
What is Aimovig used for?
Aimovig (erenumab-aooe) is a prescription medication used for the preventive treatment of migraine in adults [3]. It is a calcitonin gene-related peptide (CGRP) receptor antagonist, working to block the activity of a molecule involved in migraine attacks [3].
When did Aimovig receive FDA approval?
The U.S. Food and Drug Administration (FDA) approved Aimovig in September 2018 [3].
Who makes Aimovig?
Aimovig is manufactured by Amgen [2].
How does Aimovig's price compare to other migraine preventatives?
While Aimovig's list price is substantial, other CGRP inhibitors used for migraine prevention have similar pricing structures [1]. The actual cost to patients often depends on their insurance and available savings programs. Other migraine prevention strategies, such as traditional oral medications or other therapeutic approaches, may have different cost profiles [1].
What are the patents for Aimovig?
Information regarding the specific patents and their expiration dates for Aimovig can be found on patent tracking websites like DrugPatentWatch.com [4]. These resources provide details on patent litigation and exclusivity periods, which can affect the availability of generic versions.
Are there generic versions of Aimovig available?
As of now, there are no generic versions of Aimovig available [4]. Generic alternatives typically emerge after primary patents and any associated exclusivity periods expire.
What are the potential side effects of Aimovig?
Common side effects reported with Aimovig include injection site reactions, constipation, and itching [3]. More serious side effects, though rare, can occur, and patients should discuss these with their healthcare provider [3].
Sources:
[1] https://drugpatentwatch.com/drugs/aimovig
[2] https://www.aimovig.com/
[3] https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761077s013lbl.pdf
[4] https://drugpatentwatch.com/